{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:04:26Z","timestamp":1789963466908,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/ncpcardio0721","type":"journal-article","created":{"date-parts":[[2006,11,23]],"date-time":"2006-11-23T09:44:42Z","timestamp":1164275082000},"page":"656-663","source":"Crossref","is-referenced-by-count":22,"title":["Therapy for early reperfusion after stroke"],"prefix":"10.1038","volume":"3","author":[{"given":"Eric","family":"Juttler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Schellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpcardio0721_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/01.STR.12.6.723","volume":"12","author":"J Astrup","year":"1981","unstructured":"Astrup J et al. (1981) Thresholds in cerebral ischemia\u2014the ischemic penumbra. Stroke 12: 723\u2013725","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/jcbfm.1994.120","volume":"14","author":"WD Heiss","year":"1994","unstructured":"Heiss WD et al. (1994) Dynamic penumbra demonstrated by sequential multi-tracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 14: 892\u2013902","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFncpcardio0721_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1097\/00004647-200009000-00002","volume":"20","author":"WD Heiss","year":"2000","unstructured":"Heiss WD (2000) Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 20: 1276\u20131293","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFncpcardio0721_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ana.410360404","volume":"36","author":"KA Hossmann","year":"1994","unstructured":"Hossmann KA (1994) Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36: 557\u2013565","journal-title":"Ann Neurol"},{"key":"BFncpcardio0721_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/BF01700973","volume":"21","author":"W Hacke","year":"1995","unstructured":"Hacke W et al. (1995) Critical care of acute ischemic stroke. Int Care Med 21: 856\u2013862","journal-title":"Int Care Med"},{"key":"BFncpcardio0721_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3171\/jns.1981.54.6.0773","volume":"54","author":"TH Jones","year":"1981","unstructured":"Jones TH et al. (1981) Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54: 773\u2013782","journal-title":"J Neurosurg"},{"key":"BFncpcardio0721_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/00003246-200109000-00027","volume":"29","author":"PD Schellinger","year":"2001","unstructured":"Schellinger PD et al. (2001) Thrombolytic therapy for ischemic stroke\u2014a review: part I intravenous thrombolysis. Crit Care Med 29: 1812\u20131818","journal-title":"Crit Care Med"},{"key":"BFncpcardio0721_CR8","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1097\/00003246-200109000-00028","volume":"29","author":"PD Schellinger","year":"2001","unstructured":"Schellinger PD et al. (2001) Thrombolytic therapy for ischemic stroke\u2014a review: part II intraarterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med 29: 1819\u20131825","journal-title":"Crit Care Med"},{"key":"BFncpcardio0721_CR9","first-page":"727","volume":"88","author":"AD Morris","year":"1995","unstructured":"Morris AD et al. (1995) A pilot study of streptokinase for acute cerebral infarction. QJM 88: 727\u2013731","journal-title":"QJM"},{"key":"BFncpcardio0721_CR10","doi-asserted-by":"crossref","unstructured":"Multicentre Acute Stroke Trial\u2013Italy (MAST-I) Group (1995) Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 346: 1509\u20131514","DOI":"10.1016\/S0140-6736(95)92049-8"},{"key":"BFncpcardio0721_CR11","doi-asserted-by":"crossref","unstructured":"The Multicenter Acute Stroke Trial\u2013Europe Study Group (1996) Thrombolytic therapy with streptokinase with acute ischemic stroke. N Engl J Med 335: 145\u2013150","DOI":"10.1056\/NEJM199607183350301"},{"key":"BFncpcardio0721_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","volume":"276","author":"GA Donnan","year":"1996","unstructured":"Donnan GA et al. (1996) Streptokinase for acute ischemic stroke with relationship to the time of administration. Australian Streptokinase (ASK) Trial Study Group. JAMA 276: 961\u2013966","journal-title":"JAMA"},{"key":"BFncpcardio0721_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1161\/01.STR.31.7.1555","volume":"31","author":"C Cornu","year":"2000","unstructured":"Cornu C et al. (2000) Streptokinase in acute ischemic stroke: an individual patient data meta-analysis. The Thrombolysis in Acute Stroke Pooling Project. Stroke 31: 1555\u20131560","journal-title":"Stroke"},{"issue":"Suppl 3","key":"BFncpcardio0721_CR14","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.2165\/00003495-199700543-00013","volume":"54","author":"GJ Del Zoppo","year":"1997","unstructured":"Del Zoppo GJ (1997) Thrombolytic therapy in the treatment of stroke. Drugs 54 (Suppl 3): S90\u2013S99","journal-title":"Drugs"},{"key":"BFncpcardio0721_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1212\/WNL.42.5.976","volume":"42","author":"E Mori","year":"1992","unstructured":"Mori E et al. (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976\u2013982","journal-title":"Neurology"},{"key":"BFncpcardio0721_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000108714","volume":"3","author":"T Yamaguchi","year":"1993","unstructured":"Yamaguchi T et al. (1993) Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3: 269\u2013272","journal-title":"Cerebrovasc Dis"},{"key":"BFncpcardio0721_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.STR.24.7.1000","volume":"24","author":"EC Haley Jr","year":"1993","unstructured":"Haley EC Jr et al. (1993) Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke 24: 1000\u20131004","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR18","doi-asserted-by":"crossref","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581\u20131587","DOI":"10.1056\/NEJM199512143332401"},{"key":"BFncpcardio0721_CR19","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke W et al. (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study. JAMA 274: 1017\u20131025","journal-title":"JAMA"},{"key":"BFncpcardio0721_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W et al. (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 352: 1245\u20131251","journal-title":"Lancet"},{"key":"BFncpcardio0721_CR21","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","volume":"282","author":"WM Clark","year":"1999","unstructured":"Clark WM et al. (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset\u2014the ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282: 2019\u20132026","journal-title":"JAMA"},{"key":"BFncpcardio0721_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","volume":"31","author":"WM Clark","year":"2000","unstructured":"Clark WM et al. (2000) The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke 31: 811\u2013816","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"W Hacke","year":"2004","unstructured":"Hacke W et al. (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768\u2013774","journal-title":"Lancet"},{"key":"BFncpcardio0721_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","volume":"36","author":"EC Haley Jr","year":"2005","unstructured":"Haley EC Jr et al. TNK in Stroke Investigators (2005) A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36: 607\u2013612","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","volume":"36","author":"W Hacke","year":"2005","unstructured":"Hacke W et al. DIAS Study Group (2005) The Desmopletase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9 hour window acute stroke thrombolysis trial with intravenous desmopletase. Stroke 36: 66\u201373","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.STR.0000217403.66996.6d","volume":"37","author":"AJ Furlan","year":"2006","unstructured":"Furlan AJ et al. DEDAS Investigators (2006) Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37: 1227\u20131231","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR27","first-page":"769","volume":"27","author":"RM Sugg","year":"2006","unstructured":"Sugg RM et al. (2006) Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. Am J Neuroradiol 27: 769\u2013773","journal-title":"Am J Neuroradiol"},{"key":"BFncpcardio0721_CR28","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V73.7.1864.1864","volume":"73","author":"HR Lijnen","year":"1989","unstructured":"Lijnen HR et al. (1989) The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in plasma milieu in vitro. Blood 73: 1864\u20131872","journal-title":"Blood"},{"key":"BFncpcardio0721_CR29","first-page":"659","volume":"13","author":"J Atarashi","year":"1985","unstructured":"Atarashi J et al. (1985) Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis: multi-center double blind study in comparison with placebo [Japanese]. Clin Eval 13: 659\u2013709","journal-title":"Clin Eval"},{"key":"BFncpcardio0721_CR30","first-page":"711","volume":"15","author":"E Ohtomo","year":"1985","unstructured":"Ohtomo E et al. (1985) Clinical efficacy of urokinase in the treatment of cerebral thrombosis: multi-center double blind study in comparison with placebo [Japanese]. Clin Eval 15: 711\u2013731","journal-title":"Clin Eval"},{"key":"BFncpcardio0721_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2491\/jjsth1970.12.321","volume":"12","author":"T Abe","year":"1981","unstructured":"Abe T et al. (1981) Clinical evaluation for efficacy of tissue cultured urokinase (tcuk) on cerebral thrombosis by means of multi-centre double blind study [Japanese]. Blood-Vessel 12: 321\u2013341","journal-title":"Blood-Vessel"},{"key":"BFncpcardio0721_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","volume":"29","author":"GJ Del Zoppo","year":"1998","unstructured":"Del Zoppo GJ et al. (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29: 4\u201311","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/01.STR.19.3.307","volume":"19","author":"GJ Del Zoppo","year":"1988","unstructured":"Del Zoppo GJ et al. (1988) Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 19: 307\u2013313","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR34","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"282","author":"A Furlan","year":"1999","unstructured":"Furlan A et al. (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003\u20132011","journal-title":"JAMA"},{"key":"BFncpcardio0721_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000069493","volume":"15","author":"B Eckert","year":"2003","unstructured":"Eckert B et al. (2003) Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization. Cerebrovasc Dis 15: 258\u2013263","journal-title":"Cerebrovasc Dis"},{"key":"BFncpcardio0721_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0006-8993(01)02735-4","volume":"912","author":"ZG Zhang","year":"2001","unstructured":"Zhang ZG et al. (2001) Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 912: 181\u2013194","journal-title":"Brain Res"},{"key":"BFncpcardio0721_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.me.43.020192.001131","volume":"43","author":"BS Coller","year":"1992","unstructured":"Coller BS (1992) Antiplatelet agents in the prevention and therapy of thrombosis. Ann Rev Med 43: 171\u2013180","journal-title":"Ann Rev Med"},{"issue":"Suppl","key":"BFncpcardio0721_CR38","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1053\/hj.1998.v136.93434","volume":"136","author":"NS Kleiman","year":"1998","unstructured":"Kleiman NS et al. (1998) Glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings. Am Heart J 136 (Suppl): S32\u2013S42","journal-title":"Am Heart J"},{"key":"BFncpcardio0721_CR39","doi-asserted-by":"crossref","unstructured":"Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators (2005) Emergency administration of abciximab for treatment of patients with acute ischemic stroke. Stroke 36: 880\u2013890","DOI":"10.1161\/01.STR.0000157668.39374.56"},{"key":"BFncpcardio0721_CR40","unstructured":"The SaTIS Investigators (2006) The Safety of Tirofiban in Acute Ischemic Stroke (SaTIS) Presented at the 15th European Stroke Conference: 2006 May 16\u201319, Brussels"},{"key":"BFncpcardio0721_CR41","doi-asserted-by":"crossref","unstructured":"CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349: 1641\u20131649","DOI":"10.1016\/S0140-6736(97)04010-5"},{"key":"BFncpcardio0721_CR42","doi-asserted-by":"crossref","unstructured":"International Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349: 1569\u20131581","DOI":"10.1016\/S0140-6736(97)04011-7"},{"key":"BFncpcardio0721_CR43","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71\u201386","DOI":"10.1136\/bmj.324.7329.71"},{"key":"BFncpcardio0721_CR44","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/01.STR.0000185730.50480.e7","volume":"36","author":"M Camerlingo","year":"2005","unstructured":"Camerlingo M et al. (2005) Intravenous heparin starter within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36: 2415\u20132420","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000086100","volume":"19","author":"A Chamorro","year":"2005","unstructured":"Chamorro A et al. (2005) The rapid anticoagulation prevents ischemic damage study in acute stroke\u2014final results from the writing committee. Cerebrovasc Dis 19: 402\u2013404","journal-title":"Cerebrovasc Dis"},{"key":"BFncpcardio0721_CR46","unstructured":"Berge E and Sandercock P (1992) Anticoagulants versus antiplatelet agents for acute ischemic stroke. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD003242"},{"key":"BFncpcardio0721_CR47","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1161\/01.STR.0000147718.12954.60","volume":"35","author":"YP Gobin","year":"2004","unstructured":"Gobin YP et al. (2004) MERCI 1: a phase I study of mechanical embolus removal in cerebral ischemia. Stroke 35: 2848\u20132854","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR48","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/01.STR.30.12.2598","volume":"30","author":"CA Lewandowski","year":"1999","unstructured":"Lewandowski CA et al. (1999) Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) bridging trial. Stroke 30: 2598\u20132605","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR49","doi-asserted-by":"crossref","unstructured":"IMS Study Investigators (2004) Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35: 904\u2013911","DOI":"10.1161\/01.STR.0000121641.77121.98"},{"key":"BFncpcardio0721_CR50","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.CIR.0000068374.57764.EB","volume":"107","author":"L Zhang","year":"2003","unstructured":"Zhang L et al. (2003) Adjuvant treatment with a glycoprotein IIb\/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation 107: 2837\u20132843","journal-title":"Circulation"},{"key":"BFncpcardio0721_CR51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1051-0443(07)61984-8","volume":"13","author":"DH Lee","year":"2002","unstructured":"Lee DH et al. (2002) Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 13: 769\u2013774","journal-title":"J Vasc Interv Radiol"},{"key":"BFncpcardio0721_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1227\/01.NEU.0000145785.69942.B3","volume":"56","author":"VR Deshmukh","year":"2005","unstructured":"Deshmukh VR et al. (2005) Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb\/IIIa inhibitors as adjunctive therapy. Neurosurgery 56: 46\u201354","journal-title":"Neurosurgery"},{"key":"BFncpcardio0721_CR53","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1056\/NEJMoa041175","volume":"351","author":"A Alexandrov","year":"2004","unstructured":"Alexandrov A et al. CLOTBUST Investigators (2004) Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351: 2170\u20132178","journal-title":"N Engl J Med"},{"key":"BFncpcardio0721_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.STR.0000199064.94588.39","volume":"37","author":"C Molina","year":"2006","unstructured":"Molina C et al. (2006) Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37: 425\u2013429","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR55","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1161\/01.STR.0000170707.86793.1a","volume":"36","author":"M Daffertshofer","year":"2005","unstructured":"Daffertshofer M et al. (2005) Transcranial low frequency ultrasound mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II trial. Stroke 36: 1441\u20131446","journal-title":"Stroke"},{"key":"BFncpcardio0721_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17434440.3.1.113","volume":"3","author":"E Juttler","year":"2006","unstructured":"Juttler E et al. (2006) Diagnostic imaging for acute ischemic stroke management. Expert Rev Med Dev 3: 113\u2013126","journal-title":"Expert Rev Med Dev"},{"key":"BFncpcardio0721_CR57","unstructured":"Albers G et al. (online 2004) DEFUSE Study [ http:\/\/strokecenter.stanford.edu\/trials\/defuse.html ] (accessed 25 October 2006)"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0721","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpcardio0721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:39:56Z","timestamp":1684438796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio0721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BFncpcardio0721"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio0721","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}